Connect
MJA
MJA

Emergence of hetero-vancomycin-intermediate Staphylococcus aureus (hVISA) in Sydney

Iain B Gosbell, David H Mitchell, Helen Ziochos and Peter B Ward
Med J Aust 2003; 178 (7): 354.
Published online: 7 April 2003

To the Editor: Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (vancomycin-intermediate S. aureus, or VISA) was initially described in Japan,1 then the United States,2 and subsequently other regions of the world. Recently, Ward and colleagues reported the initial Australian isolate — a heteroresistant VISA (hVISA) strain — in Melbourne, Victoria.3 We report the first isolation of hVISA in Sydney, New South Wales.

  • Iain B Gosbell
  • David H Mitchell
  • Helen Ziochos
  • Peter B Ward


Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.